Literature DB >> 13876641

Effect of sancylates on plasmafree fatty acid in normal and diabetic subjects.

L A CARLSON, J OSIMAN.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/blood; FATTY ACIDS/blood; SALICYLATES/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13876641

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  8 in total

1.  The action of salicylate in reducing plasma free fatty acids and its pharmacological consequences.

Authors:  A Bizzi; S Garattini; E Veneroni
Journal:  Br J Pharmacol Chemother       Date:  1965-08

Review 2.  Aspirin and exercise as a prophylaxis for heart disease. Is it safe?

Authors:  R E De Meersman
Journal:  Sports Med       Date:  1990-02       Impact factor: 11.136

Review 3.  Antilipolysis as a tool in the study of clinical and experimental diabetes. Lecture for the 1968 Minkowski Award.

Authors:  L A Carlson
Journal:  Diabetologia       Date:  1969-12       Impact factor: 10.122

4.  The effect of 3-methyl salicylic (O-cresotinic) acid on plasma insulin and glucose tolerance in diabetic and non-diabetic subjects.

Authors:  D E Hyams; A N Howard; I E Evans; S H Davison
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

5.  The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man.

Authors:  D Giugliano; R Torella; N Siniscalchi; L Improta; F D'Onofrio
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

6.  Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.

Authors:  D Giugliano; N Passariello; R Torella; T Cerciello; M Varricchio; S Sgambato
Journal:  Acta Diabetol Lat       Date:  1981

7.  The effect of salsalate therapy on endothelial function in a broad range of subjects.

Authors:  Anju Nohria; Scott Kinlay; J Stewart Buck; Whitney Redline; Robert Copeland-Halperin; Sora Kim; Joshua A Beckman
Journal:  J Am Heart Assoc       Date:  2014-01-03       Impact factor: 5.501

8.  Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.

Authors:  Sandrine Ellero-Simatos; Amber L Beitelshees; Joshua P Lewis; Laura M Yerges-Armstrong; Anastasia Georgiades; Adrie Dane; Amy C Harms; Katrin Strassburg; Faisa Guled; Margriet M W B Hendriks; Richard B Horenstein; Alan R Shuldiner; Thomas Hankemeier; Rima Kaddurah-Daouk
Journal:  J Am Heart Assoc       Date:  2015-10-26       Impact factor: 5.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.